Search Results - Nedjatian, N.

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Traitement de substitution par l’hormone de croissance (GH) chez les patients âgés de ≥ 60 ans présentant un déficit en GH chez l’adulte (AGHD) : données de NordiNet® IOS et du programme ANSWER

    Traitement de substitution par l’hormone de croissance (GH) chez les patients âgés de ≥ 60 ans présentant un déficit en GH chez l’adulte (AGHD) : données de NordiNet® IOS et du pro... by Weber, M.M., Gordon, M.B., Höybye, C., Olsen, A.H., Kelepouris, N.K., Nedjatian, N., Biller, B.M.B.

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Effets du somapacitan sur le métabolisme du glucose chez les adultes présentant un déficit en GH (AGHD)

    Effets du somapacitan sur le métabolisme du glucose chez les adultes présentant un déficit en GH (AGHD) by Johannsson, G., Biller, B., Hidenori, F., Ho, K., Rasmussen, M.H., Nedjatian, N., Sværke, C., Yuen, K., Takahashi, Y.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program

    Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enab... by Biller, Beverly M. K., Höybye, Charlotte, Carroll, Paul, Gordon, Murray B., Birkegård, Anna Camilla, Kelepouris, Nicky, Nedjatian, Navid, Weber, Matthias M.

    Published in Pituitary
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency

    Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency by Takahashi, Yutaka, Biller, Beverly M. K., Fukuoka, Hidenori, Ho, Ken K. Y., Rasmussen, Michael Højby, Nedjatian, Navid, Sværke, Claus, Yuen, Kevin C. J., Johannsson, Gudmundur

    Published in Pituitary
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Reduced CV risk with long-term GH replacement in AGHD: data from two large observational studies

    Reduced CV risk with long-term GH replacement in AGHD: data from two large observational studies by Höybye, Charlotte, Biller, Beverly M K, Ferran, Jean-Marc, Gordon, Murray B, Kelepouris, Nicky, Nedjatian, Navid, Olsen, Anne H, Weber, Matthias M

    Published in Endocrine Connections
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER

    Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER by Biller, Beverly M K, Höybye, Charlotte, Ferran, Jean-Marc, Kelepouris, Nicky, Nedjatian, Navid, Olsen, Anne Helene, Weber, Matthias M, Gordon, Murray B

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: